JENNIFER PANTOLIANO: Open Payments
NPI 1295277572 · STONY BROOK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$209 in 8 payments from 7 companies in 2025. Trend: 2023 $664 · 2024 $355 · 2025 $209
Food & beverage: $209
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $54 |
| Calliditas Therapeutics US Inc. | 1 | $39 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| Daiichi Sankyo Inc. | 1 | $26 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $26 |
| Amgen Inc. | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: Kerendia, TARPEYO, JYNARQUE, INJECTAFER, JARDIANCE, KRYSTEXXA, FARXIGA.
Industry payments across NY — which companies pay providers there.
